Similarly, simultaneous activation of FXR and TGR5 by the dual agonist INT-767 in Ldlr−/− mice reduced atherosclerosis via anti-inflammatory and lipid-lowering effects [117]. Here, NR1H4 is linked to atherosclerosis.